ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,249.98
0.37%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. DiaMedica Therapeutics Inc (DMAC)

  7. DiaMedica Therapeutics Inc (DMAC) Noticias

DMAC DiaMedica Therapeutics Inc

2.40
0.05 (2.13%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
DiaMedica Therapeutics Inc DMAC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.05 2.13% 2.40 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.35 2.34 2.50 2.40 2.35
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202415:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/5/202415:00EDGAR2Form 8-K - Current report
08/5/202415:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202415:30EDGAR2Form 8-K - Current report
08/5/202415:30BWDiaMedica Therapeutics Provides a Business Update and..
02/5/202407:55BWDiaMedica Therapeutics to Report First Quarter 2024..
17/4/202415:08BWDiaMedica Therapeutics Announces First Patient Dosed in..
19/3/202415:15BWDiaMedica Therapeutics Provides a Business Update and..
29/1/202415:13BWDiaMedica Therapeutics Announces Poster Presentation at..
23/1/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202415:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/1/202407:23BWDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as..
02/1/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:52EDGAR2Form 8-K - Current report
13/11/202315:28BWDiaMedica Therapeutics Provides a Business Update and..
09/11/202307:25BWDiaMedica Therapeutics to Attend the 14th Annual..
06/11/202307:23BWDiaMedica Therapeutics to Report Third Quarter 2023..
12/9/202307:13BWDiaMedica Therapeutics Announces the Appointment of Ambarish..
06/9/202307:35BWDiaMedica Therapeutics to Participate at Lake Street’s 7th..
05/9/202315:15EDGAR2Form 8-K - Current report
14/8/202315:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:25EDGAR2Form 8-K - Current report
14/8/202315:13BWDiaMedica Therapeutics Provides a Business Update and..
08/8/202307:32BWDiaMedica Therapeutics to Report Second Quarter 2023..
18/7/202307:30BWDiaMedica Therapeutics to Attend the American Academy of..
10/7/202315:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/7/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
30/6/202315:16EDGAR2Form S-3 - Registration statement under Securities Act of..
26/6/202307:30BWDiaMedica Therapeutics Announces Closing of $37.5 Million..
21/6/202307:39BWDiaMedica Therapeutics Announces $37.5 Million Private..
21/6/202307:15BWDiaMedica Therapeutics Announces that the FDA Has Removed..

Su Consulta Reciente

NASDAQ
DMAC
DiaMedica Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados